搜索
产品
社区
市场
新闻
经纪商
更多
CN
开始
BIOGEN (BIIB)
做多
Biogen Inc.
(
NASDAQ:BIIB
)
mgiuliani
Essential
NASDAQ:BIIB
Biogen Inc.
12
2
We think the company has a above average capital gains return. The comèany has taken a lot of debt, and we belive that that debt will be used soon to make an acquisition. Potential target is Shire Pharma.
相关观点
Standard & Poor's (SPX)
mgiuliani
Essential
about
SPX
8
EURUSD
mgiuliani
Essential
about
EURUSD
1
S&P500 (SPX)
mgiuliani
Essential
about
SPX
5
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款
阅读更多信息。